首页|Birmingham and Midland Eye Centre Reports Findings in Artificial Intelligence (C oncordance of randomised controlled trials for artificial intelligence intervent ions with the CONSORT-AI reporting guidelines)
Birmingham and Midland Eye Centre Reports Findings in Artificial Intelligence (C oncordance of randomised controlled trials for artificial intelligence intervent ions with the CONSORT-AI reporting guidelines)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Artificial Intelligenc e is the subject of a report. According to news reporting originating in Birming ham, United Kingdom, by NewsRx journalists, research stated, "The Consolidated S tandards of Reporting Trials extension for Artificial Intelligence interventions (CONSORTAI) was published in September 2020. Since its publication, several ra ndomised controlled trials (RCTs) of AI interventions have been published but th eir completeness and transparency of reporting is unknown." The news reporters obtained a quote from the research from Birmingham and Midlan d Eye Centre, "This systematic review assesses the completeness of reporting of AI RCTs following publication of CONSORT-AI and provides a comprehensive summary of RCTs published in recent years. 65 RCTs were identified, mostly conducted in China (37%) and USA (18%). Median concordance with CO NSORT-AI reporting was 90% (IQR 77-94%), although onl y 10 RCTs explicitly reported its use. Several items were consistently under-rep orted, including algorithm version, accessibility of the AI intervention or code, and references to a study protocol. Only 3 of 52 included journals explicitly endorsed or mandated CONSORTAI. Despite a generally high concordance amongst re cent AI RCTs, some AI-specific considerations remain systematically poorly repor ted."
NETL
NSTL
